Pre-erythrocytic vaccines |
PfCSP vaccines |
Subunit vaccines |
PfCSP |
Antibodies to PfCSP block the sporozoite invasion of liver cells |
[5, 6] |
RTS,S/AS01 and RTS,S/AS02 |
Hepatitis B surface antigen and the central repeat and C-terminal regions of CSP |
Protective immune responses after vaccination with RTS,S are dependent primarily on antibody responses against the central repeat region |
[7–11] |
PfCSP bacteria vaccines |
PfCSP |
Bacteria need assistance to stimulate the innate immune system |
[12, 13] |
TRAP vaccines |
Subunit vaccines |
SSP-2 |
Antibodies to SSP-2 block the invasion of mosquito salivary glands and hepatocytes |
[14] |
LSA vaccines |
Subunit vaccines |
LSA-1/LSA-3 |
Elicit a pre-erythrocyte antigen response in the majority of individuals from different age groups |
[15–18] |
PfSPZ vaccines |
Live attenuated vaccines |
PfSPZ |
Antibodies to PfSPZ block the parasite arrival to the liver or during their development in this organ |
[3] |
|
Asexual blood-stage vaccines |
MSP1 vaccines |
Subunit vaccines |
MSP142/MSP138/MSP183
|
Antibodies to MSP1 to block the parasite invasion of erythrocyte |
[19] |
AMA-1 vaccines |
Subunit vaccines |
AMA-1 |
AMA-1 plays an essential role in parasite survival. Antibodies to AMA-1 may kill the parasite |
[20–22] |
Rh5 vaccines |
Subunit vaccines |
Rh5 |
Antibodies to Rh5 block the parasite invasion of erythrocyte by forming complex with cyrpa and ripr |
[23–25] |
|
Transmission-blocking vaccines |
Pfs25 vaccines |
Subunit vaccines |
Pfs25 |
Pfs25 is the target on which the parasite survives and interacts with the mosquito midgut. Antibodies to Pfs25 control the transmission of malaria parasites from human hosts to the mosquito vectors |
[26–28] |
Pfs48/45 vaccines |
Subunit vaccines |
Pfs48/45 C-terminus |
Pfs48/45 is the target on which male gamete attaches to female gamete. Antibodies to Pfs48/45 can induce transmission-blocking antibody response during infection |
[29] |